Antidandruff Lotion Mediating Microbiome Rebalance
← catalyst calendarSponsored by L'Oreal (industry) · OR.PA — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · Triple · Treatment
Enrollment
120estimated
Sites
1
Country
Portugal
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-09-01 | actual | When the study began enrolling |
| Primary completion | 2025-05-02 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-06-01 | estimated | The whole study's end, after follow-up |
| First posted | 2025-02-07 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-02-07 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Dandruff
Interventions
- Other: NaP1%+VitCG3% leave-on lotion (formula 1256103)
- Other: vehicle (formula 1256145)
- Other: reference Octopirox 0.25% (formula 1256149).
Primary outcome
what the primary-completion date above is the date OFGlobal score of dandruff status of the scalp: evaluation of adherent and non-adherent dandruff according
measured Day 0 and Day 28
Permalink · OR.PA's whole pipeline · Catalyst calendar · Every registered study · What changed